Eidogen-Sertanty Licenses Target Informatics Platform to NCBI
News Mar 10, 2006
Eidogen-Sertanty, Inc. has announced that they have licensed their Target Informatics Platform™ (TIP™) to the U.S. National Library of Medicine’s National Center for Biotechnology Information (NCBI), based in Bethesda, MD.
Under the terms of the annual license, scientists at the NCBI will have access to the TIP structural knowledgebase as well as Eidogen-Sertanty’s EVE Comparative Visualizer.
"We’re extremely pleased to be collaborating with the NCBI. They have developed a number of outstanding and widely used informatics platforms over the years, and I’m optimistic that our interaction will lead to new high impact advances," said Derek Debe, Eidogen-Sertanty’s Chief Scientific Officer.
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.
Researchers published today a detailed description of the complete genome of bread wheat, the world's most widely-cultivated crop. This work will pave the way for the production of wheat varieties better adapted to climate challenges, with higher yields, enhanced nutritional quality and improved sustainability.